Upper limb muscle atrophy associated with in-hospital mortality and physical function impairments in mechanically ventilated critically ill adults: a two-center prospective observational study.
Critically ill patients
In-hospital mortality
Muscle atrophy
Ultrasonography
Upper limb
Journal
Journal of intensive care
ISSN: 2052-0492
Titre abrégé: J Intensive Care
Pays: England
ID NLM: 101627304
Informations de publication
Date de publication:
23 Nov 2020
23 Nov 2020
Historique:
received:
17
09
2020
accepted:
11
11
2020
entrez:
9
12
2020
pubmed:
10
12
2020
medline:
10
12
2020
Statut:
epublish
Résumé
Lower limb muscle atrophy is often observed in critically ill patients. Although upper limb muscles can undergo atrophy, it remains unclear how this atrophy is associated with clinical outcomes. We hypothesized that this atrophy is associated with mortality and impairments in physical function. In this two-center prospective observational study, we included adult patients who were expected to require mechanical ventilation for > 48 h and remain in the intensive care unit (ICU) for > 5 days. We used ultrasound to evaluate the cross-sectional area of the biceps brachii on days 1, 3, 5, and 7 and upon ICU discharge along with assessment of physical functions. The primary outcome was the relationship between muscle atrophy ratio and in-hospital mortality on each measurement day, which was assessed using multivariate analysis. The secondary outcomes were the relationships between upper limb muscle atrophy and Medical Research Council (MRC) score, handgrip strength, ICU Mobility Scale (IMS) score, and Functional Status Score for the ICU (FSS-ICU). Sixty-four patients (43 males; aged 70 ± 13 years) were enrolled. The Acute Physiology and Chronic Health Evaluation (APACHE) II score was 27 (22-30), and in-hospital mortality occurred in 21 (33%) patients. The decreased cross-sectional area of the biceps brachii was not associated with in-hospital mortality on day 3 (p = 0.43) but was associated on days 5 (p = 0.01) and 7 (p < 0.01), which was confirmed after adjusting for sex, age, and APACHE II score. In 27 patients in whom physical functions were assessed, the decrease of the cross-sectional area of the biceps brachii was associated with MRC score (r = 0.47, p = 0.01), handgrip strength (r = 0.50, p = 0.01), and FSS-ICU (r = 0.56, p < 0.01), but not with IMS score (r = 0.35, p = 0.07) upon ICU discharge. Upper limb muscle atrophy was associated with in-hospital mortality and physical function impairments; thus, it is prudent to monitor it. (321 words) TRIAL REGISTRATION: UMIN 000031316 . Retrospectively registered on 15 February 2018.
Sections du résumé
BACKGROUND
BACKGROUND
Lower limb muscle atrophy is often observed in critically ill patients. Although upper limb muscles can undergo atrophy, it remains unclear how this atrophy is associated with clinical outcomes. We hypothesized that this atrophy is associated with mortality and impairments in physical function.
METHODS
METHODS
In this two-center prospective observational study, we included adult patients who were expected to require mechanical ventilation for > 48 h and remain in the intensive care unit (ICU) for > 5 days. We used ultrasound to evaluate the cross-sectional area of the biceps brachii on days 1, 3, 5, and 7 and upon ICU discharge along with assessment of physical functions. The primary outcome was the relationship between muscle atrophy ratio and in-hospital mortality on each measurement day, which was assessed using multivariate analysis. The secondary outcomes were the relationships between upper limb muscle atrophy and Medical Research Council (MRC) score, handgrip strength, ICU Mobility Scale (IMS) score, and Functional Status Score for the ICU (FSS-ICU).
RESULTS
RESULTS
Sixty-four patients (43 males; aged 70 ± 13 years) were enrolled. The Acute Physiology and Chronic Health Evaluation (APACHE) II score was 27 (22-30), and in-hospital mortality occurred in 21 (33%) patients. The decreased cross-sectional area of the biceps brachii was not associated with in-hospital mortality on day 3 (p = 0.43) but was associated on days 5 (p = 0.01) and 7 (p < 0.01), which was confirmed after adjusting for sex, age, and APACHE II score. In 27 patients in whom physical functions were assessed, the decrease of the cross-sectional area of the biceps brachii was associated with MRC score (r = 0.47, p = 0.01), handgrip strength (r = 0.50, p = 0.01), and FSS-ICU (r = 0.56, p < 0.01), but not with IMS score (r = 0.35, p = 0.07) upon ICU discharge.
CONCLUSIONS
CONCLUSIONS
Upper limb muscle atrophy was associated with in-hospital mortality and physical function impairments; thus, it is prudent to monitor it. (321 words) TRIAL REGISTRATION: UMIN 000031316 . Retrospectively registered on 15 February 2018.
Identifiants
pubmed: 33292655
doi: 10.1186/s40560-020-00507-7
pii: 10.1186/s40560-020-00507-7
pmc: PMC7684934
doi:
Types de publication
Journal Article
Langues
eng
Pagination
87Références
Am J Respir Crit Care Med. 2017 Jan 1;195(1):136-138
pubmed: 28035857
Crit Care. 2019 Sep 10;23(1):308
pubmed: 31506074
J Crit Care. 2018 Dec;48:1-8
pubmed: 30118978
J Crit Care. 2018 Oct;47:324-330
pubmed: 30224027
Crit Care Med. 2020 Nov;48(11):e997-e1003
pubmed: 32897665
Intensive Care Med. 2018 Feb;44(2):263-264
pubmed: 29110031
Crit Care Med. 2009 Oct;37(10 Suppl):S299-308
pubmed: 20046114
Crit Care Med. 2008 Aug;36(8):2238-43
pubmed: 18596631
Crit Care Med. 2018 Nov;46(11):1769-1774
pubmed: 30095496
Chest. 2020 Jul;158(1):183-194
pubmed: 32247714
Crit Care. 2016 Jan 29;20:30
pubmed: 26825278
J Med Invest. 2020;67(1.2):1-10
pubmed: 32378591
Crit Care. 2015 Jul 02;19:266
pubmed: 26134116
Intensive Care Med. 2020 Jun;46(6):1184-1193
pubmed: 31970446
Crit Care. 2014 Jan 13;18(2):R12
pubmed: 24410863
Acute Med Surg. 2019 Apr 25;6(3):233-246
pubmed: 31304024
J Crit Care. 2010 Jun;25(2):254-62
pubmed: 19942399
JAMA. 2018 Jul 24;320(4):368-378
pubmed: 30043066
Crit Care. 2015 Mar 29;19:127
pubmed: 25888469
Am J Respir Crit Care Med. 2008 Aug 1;178(3):261-8
pubmed: 18511703
Crit Care Med. 2020 Sep;48(9):1312-1318
pubmed: 32639412
JAMA. 2002 Dec 11;288(22):2859-67
pubmed: 12472328
Clin Nutr. 2020 Aug 7;:
pubmed: 32800385
BMC Geriatr. 2017 Oct 16;17(1):238
pubmed: 29037155
Crit Care Med. 2020 Sep;48(9):1327-1333
pubmed: 32706557
Ann Am Thorac Soc. 2019 Sep;16(9):1107-1111
pubmed: 30978111
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):734-747
pubmed: 31016887
J Crit Care. 2015 Oct;30(5):1151.e9-14
pubmed: 26211979
J Crit Care. 2020 Oct;59:86-93
pubmed: 32585438
Crit Care. 2015 Aug 05;19:274
pubmed: 26242743
BMC Anesthesiol. 2016 Nov 29;16(1):119
pubmed: 27894277
J Intensive Care. 2019 Dec 16;7:61
pubmed: 31890223
Chest. 2019 Feb;155(2):322-330
pubmed: 30392790
JAMA. 2013 Oct 16;310(15):1591-600
pubmed: 24108501
Kaohsiung J Med Sci. 2012 Dec;28(12):667-72
pubmed: 23217359
J Intensive Care. 2018 Dec 12;6:81
pubmed: 30564367
Acute Med Surg. 2020 Oct 11;7(1):e572
pubmed: 33072346
Heart Lung. 2014 Jan-Feb;43(1):19-24
pubmed: 24373338
Crit Care. 2013 Oct 07;17(5):R227
pubmed: 24499688